In the 26-week open-label period of this study, the most frequently observed laboratory abnormalities were increases in creatinine (6.5%) and increased CK values   in 2% of children receiving the product.
Ngesikhathi sokutadisha esivulekile samaviki angama-26, ukuphambuka kokujwayelekile kwezinkomba zaselabhoratri bekuvame ukubonwa kakhulu: ukwanda kwe-creatinine (6.5%) kanye nokwanda kwe-CPK (SC) kuma-2% wezingane ezamukelayo.